News
With the price of weight-loss injection Mounjaro rising by 170 per cent next month, we asked a pharmacist and medical ...
GLP-1s aren't FDA-approved to treat rheumatoid arthritis, but many people notice improvement in their inflammation with the ...
A NEW drug developed to combat diabetes and obesity melts fat at double the rate of other GLP-1 drugs, scientists say. The ...
The mother-of-two was seen in a snakeskin print push-up bra dress by L'Agence as she stopped by the Today show to talk her ...
Telehealth company Ro has a new spokesperson for its booming GLP-1 business: Serena Williams, the 23-time Grand Slam champion ...
GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly ...
16h
21Ninety on MSNSerena Williams Opens Up About GLP-1 Weight Loss, Here’s What Women Should Know
GLP-1 meds are trending after Serena Williams’ 31-pound weight loss. A doctor breaks down the side effects, safety concerns & ...
The retired tennis pro explained that she’s trying to combat the stigma associated with weight loss drugs after losing 31 ...
8h
Health and Me on MSNSerena Williams Opens Up About Losing 31 lbs With GLP-1 Medication; Is This Breaking Stigma Or Joining The Trend?
Serena Williams revealed she lost 31 pounds using GLP-1 weight-loss drugs over the course of one year, sparking conversations ...
20hon MSN
GLP-1 drugs such as Lilly’s Mounjaro and Novo’s Ozempic linked to lower cancer risk: study
Mounjaro and other GLP-1 drugs may lower cancer risk in obese patients, according to a new study. Read more here.
Sara H. Jodka of Dickinson Wright PLLC discusses the legal landscape surrounding GLP-1 programs for weight loss, in light of ...
After years of struggling with postpartum weight gain despite strict training and healthy eating, the 23-time Grand Slam ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results